Dr Reddy's raises Rs 1,077 cr debt in Q3

16 Dec 2011 Evaluate

Pharma company Dr Reddy's Laboratories has raised Rs 1,077 crore debt in the current quarter to meet working capital requirements and also refinancing old loans. In a filing to the Securities Exchange Commission, Dr Reddy's informed that one of the Company’s subsidiaries in Switzerland entered into a loan agreement with a consortium of International banks to borrow the sum of Rs 1,077.50 crore ($220 million). On October 20, 2011, the company, through its Swiss Subsidiary, drew down an amount of Rs 1,077.50 crore ($220 million) under its loan agreement dated September 28, 2011 with Citigroup Global Markets Asia Limited and the other Swiss Subsidiary Lenders. The term of the loan is for sixty months starting from September 30, 2011.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×